Emergent Health Corp
EMGE
Rank in Stocks
#34819
Emergent Health Corp. focuses on the creation and distribution of advanced... Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being. Another key offering is Neuvitale, which not only assists in nourishing stem cells but also serves as a methyl donor to safeguard DNA integrity. For appetite regulation, they provide Hungarest, a dietary aid designed to manage hunger signals originating from both the brain and stomach. Additionally, EmergentO2 is available as a water oxygenator, aiming to elevate oxygen levels within the bloodstream. The firm also develops and markets several solutions for diminishing facial wrinkles. These products are distributed through a wide network of health food stores, pharmacies, and diverse other retail channels, reaching consumers throughout the United States and globally. Based in King of Prussia, Pennsylvania, Emergent Health Corp. transitioned to private ownership as of August 26, 2014.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$4.19K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Emergent Health Corp (EMGE)
Category
Healthcare
EPS for Emergent Health Corp (EMGE)
EPS as of September 2024 TTM: $0.00
According to Emergent Health Corp's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2023 the company had an EPS of 0.00, an increase over its 2022 EPS of $-0.01.
EPS history for Emergent Health Corp from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -50.62% |
| 2023 | 0.00 | -50.62% |
| 2022 | $-0.01 | 62.00% |
| 2021 | $-0.01 | 257.14% |
| 2020 | 0.00 | 16.67% |
| 2019 | 0.00 | -124.49% |
| 2013 | 0.00 | -7.55% |
| 2012 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -406,437.50% |
DE
|
|
| $6.08 | -379,950.00% |
DE
|
|
| $1.55 | -97,012.50% |
JP
|
|
| $3.66 | -228,850.00% |
CH
|
|
| $0.45 | -28,225.00% |
IL
|
Questions about Emergent Health Corp's earnings per share (EPS)
What is Emergent Health Corp's earnings per share (EPS)?
Emergent Health Corp's earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2024.
What was Emergent Health Corp's earnings per share (EPS) in 2023?
In 2023, Emergent Health Corp's earnings per share (EPS) was 0.00, compared with $-0.01 in 2022.
How has Emergent Health Corp's earnings per share (EPS) changed since 2019?
From 2019 to 2023, Emergent Health Corp's earnings per share (EPS) was highest in 2023 (0.00) and lowest in 2022 ($-0.01).
How does Emergent Health Corp's earnings per share (EPS) compare with similar companies?
Emergent Health Corp's earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.